Brief: Catalyst Pharmaceuticals Q3 Revenue USD 128.7 Million Vs. IBES Estimate USD 123.4 Million

Catalyst Pharmaceuticals

06/11/2024 21:13

Nov 06 (Reuters) - Catalyst Pharmaceuticals Q3 net income USD 43.9 million.
* Q3 operating income USD 50.9 million vs. IBES estimate USD 51.2 million
* Q3 adjusted net income USD 71.1 million vs. IBES estimate USD 38.2 million
* outlook FY revenue USD 300-310 million